Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

8 results
Display

Discussion Meeting

Kwak YS, Bahn GH, Song DH, Ahn DH, Oh EY, Lee YS, Lee JS, Jeon SI, Cho SC, Choi SK

  • J Korean Acad Child Adolesc Psychiatry.
  • 2012 Oct;23(Suppl):S90-S95.
No abstract available.
Treatment for Attention-Deficit/Hyperactivity Disorder in Adults

Yang J, Kim JH, Kim JW, Choi J, Hong HJ, Joung YS

  • J Korean Acad Child Adolesc Psychiatry.
  • 2012 Oct;23(Suppl):S72-S89.
This review examined the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults. It briefly addresses the issues about the cause of hospital visit, diagnosis, and impact of disease, specific to adults....
Treatment of Developmental Disorders with ADHD Symptoms

Kim GM, Ahn DH, Shin SH, Suh DS, Yoo HJ, Kim YK

  • J Korean Acad Child Adolesc Psychiatry.
  • 2012 Oct;23(Suppl):S66-S71.
Developmental disorders such as mental retardation, autism spectrum disorders, and learning disorders are frequently associated with attention-deficit/hyperactivity disorder (ADHD) symptoms such as inattention, hyperactivity, and impulsivity. The existing data for...
Pharmacotherapy of Comorbid Disruptive Behavioral Disorders in Children and Adolescents with ADHD

Kang JW, Park EJ, Kim SC, Shin YJ, Shin YM, Jung J, Cheon KA, Yook KH

  • J Korean Acad Child Adolesc Psychiatry.
  • 2012 Oct;23(Suppl):S55-S65.
Disruptive behavioral disorders [oppositional defiant disorder (ODD) and conduct disorder (CD)] are common comorbid disorders in children and adolescents with attention-deficit/hyperactivity disorder (ADHD). ODD/CD may be comorbid up to 60%...
Treatment of Comorbid Anxiety and Mood Disorder in ADHD

Park EJ, Bhang SY, Seo CS, Lee YS, Hwang JW, Kwack YS

  • J Korean Acad Child Adolesc Psychiatry.
  • 2012 Oct;23(Suppl):S46-S54.
Anxiety and mood disorders are frequently comorbid with attention-deficit/hyperactivity disorder (ADHD). In this report, the characteristics of anxiety and mood disorder [major depressive disorder (MDD) and bipolar disorder] were investigated...
Safety and Tolerability of OROS Methylphenidate for the Treatment of ADHD

Kim HW, Ko BJ, Park TW, Shin YO, Lee JS, Chung US, Cho IH, Choi TY, Bahn GH

  • J Korean Acad Child Adolesc Psychiatry.
  • 2012 Oct;23(Suppl):S24-S45.
We review the effect of methylphenidate, focusing on Osmotic-controlled Release Oral delivery System (OROS) methylphenidate, on cardiovascular system, appetite and growth, sleep, tic, epilepsy, psychiatric and rare adverse events. Although...
Efficacy of OROS Methylphenidate for the Treatment of ADHD

Song J, Kim B, Son JW, Yoo HK, Lee SI, Han DH, Song DH

  • J Korean Acad Child Adolesc Psychiatry.
  • 2012 Oct;23(Suppl):S12-S23.
Attention-deficit/hyperactivity disorder (ADHD) is one of the common psychiatric problems in childhood. The symptoms of ADHD tend to last for adulthood and the patients suffer from various comorbid problems and...
Neurobiology of Attention-Deficit/Hyperactivity Disorder and the Action Mechanism of OROS Methylphenidate

Koo YJ, Lee MS, Shin DW, Kim EJ, Kang JW, Cho SC

  • J Korean Acad Child Adolesc Psychiatry.
  • 2012 Oct;23(Suppl):S5-S11.
This article is to review neurobiology of attention-deficit/hyperactivity disorder (ADHD) and pharmacological properties of Osmotic-Controlled Release Oral delivery System Methylphenidate (OROS MPH)(Concerta Oros(R)) in celebration of its one-decade clinical experiences...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr